RE:RE:RE:As a basis of comparison...It would be interesting to hear how the principal investigators or doctors are explaining the options to bladder cancer patients who are willing to participate in either TLT or Keytruda trials. I may be somewhat biased but if they were doing a good job and were not being influenced by the market cap of the trial sponsor, I cannot see how anyone would opt for the Keytruda route.